The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more ...
Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news.
By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 ...
Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...
New mRNA flu vaccine faces scrutiny ahead of key FDA decision - U.S. health advisers are debating a new kind of flu vaccine ...